AGILENT TECHNOLOGIES, INC.

Overview

Agilent Technologies is a global life sciences, diagnostics and applied-markets company. It supplies laboratory instruments, software, consumables and services used in research, clinical diagnostics and the analysis of substances and products. Its businesses span life sciences and diagnostics, laboratory services and consumables through Agilent CrossLab, and analytical instruments for applied markets.[1]+3

Agilent states that its mission is “to enable scientists to improve quality of life and the world around us.” [5] In fiscal 2025, it reported $6.95 billion in revenue and employed approximately 18,100 people worldwide, with employees across the Americas, Europe and Asia Pacific.[6][7] [1]+6

Products & services

Agilent’s analytical instruments include liquid chromatography (LC) and gas chromatography (GC) systems that separate sample components, paired with mass spectrometers that identify and quantify compounds. Its LC-MS and GC-MS ranges include single- and triple-quadrupole instruments and time-of-flight configurations; LC systems support applications such as biomolecular analysis, size-exclusion chromatography and high-throughput workflows. The portfolio also includes atomic and molecular spectroscopy instruments, dissolution-testing equipment and vacuum technologies.[8]+3

For biological and clinical laboratories, Agilent supplies SureSelect next-generation sequencing target-enrichment products, customizable gene panels, and microarrays used to detect genomic copy-number changes. Its Dako pathology range includes CoverStainer and Artisan staining systems, Dako Omnis and Autostainer immunohistochemistry systems, and companion diagnostic tests. Cell-analysis products include Seahorse platforms for metabolic analysis, xCELLigence real-time cell analyzers, NovoCyte flow cytometers and BioTek microplate readers and imaging systems. Agilent also produces clinical flow-cytometry reagents and supplies oligonucleotide active pharmaceutical ingredients through contract development and manufacturing services.[12]+4

Agilent CrossLab provides chromatography columns, sample-preparation products, laboratory supplies, automation and software for instrument control and data management. Its services include instrument repair, preventive maintenance, installation, training, compliance support, asset management and consulting, including support for instruments from other manufacturers.[17][18] [8]+10

Geographic presence

Agilent Technologies is headquartered in Santa Clara, California. In fiscal 2025, it reported $2.34 billion of revenue from the United States (33.7% of total revenue), $1.22 billion from China including Hong Kong (17.6%), and $3.38 billion from the rest of the world (48.7%). Revenue is generally assigned to countries based on customer location.[19]+2

As of October 31, 2025, Agilent employed approximately 18,100 people: 7,100 in the Americas, 4,400 in Europe and 6,600 in Asia Pacific.[7] Its disclosed manufacturing locations span the United States, Canada, China, Denmark, Germany, Malaysia, Singapore, Australia and Italy; the locations listed differ by business area.[22][23] [19]+8

Business segments

Agilent reports three business segments. In fiscal 2025, Agilent CrossLab generated approximately 42% of revenue, Life Sciences and Diagnostics Markets 39%, and Applied Markets 19%.[24]

Agilent CrossLab provides laboratory services, consumables, software and automation across end markets. Life Sciences and Diagnostics Markets supplies instruments, reagents, software and consumables for clinical and life-sciences research, as well as specialty contract development and manufacturing services for pharmaceutical customers. Applied Markets supplies instruments and software used to identify, measure and analyze the properties of substances and products.[25]

The current structure dates from a November 2024 reorganization: liquid chromatography and LC–MS instruments joined the former Diagnostics and Genomics business in Life Sciences and Diagnostics Markets; chemistries and supplies, laboratory automation, and software and informatics moved into Agilent CrossLab; and gas chromatography, GC–MS, spectroscopy, vacuum and remarketed instruments formed Applied Markets.[26] [24]+5

Company history

Agilent Technologies emerged from Hewlett-Packard’s test-and-measurement, chemical-analysis, healthcare and semiconductor businesses. HP announced the separation in March 1999; Agilent held its initial public offering that November, and HP distributed its remaining Agilent shares to shareholders in June 2000.[28] Agilent sold its healthcare business to Philips in 2001 and its semiconductor products business in 2005.[29][30]

Agilent expanded its life-sciences and diagnostics operations through the acquisition of analytical-instrument maker Varian in 2010 and diagnostics company Dako in 2012.[31][32] In 2014, it separated its electronic-measurement business into the independent company Keysight Technologies, leaving Agilent focused on life sciences, diagnostics and applied chemical markets.[33] Mike McMullen succeeded William Sullivan as CEO in 2015.[34] [31]+6

Sources

• AGILENT TECHNOLOGIES, INC. — Full financial report (2025 Y)
  23 citations

  [1][2][3][4][6][7][8][9][10][12][13][14][15][17][19][20][21][22][23][24][25][26][27]
• www.agilent.com[5]
• AGILENT TECHNOLOGIES, INC. — Full financial report (2024 Y)
  3 citations

  [11][16][18]
• www.sec.gov[28]
• www.sec.gov[29]
• www.sec.gov[30]
• AGILENT TECHNOLOGIES, INC. — Full financial report (2010 Y)[31]
• AGILENT TECHNOLOGIES, INC. — Full financial report (2012 Y)[32]
• AGILENT TECHNOLOGIES, INC. — Full financial report (2014 Y)[33]
• AGILENT TECHNOLOGIES, INC. — Full financial report (2019 Y)[34]